세계의 기침 과민 증후군 시장 보고서(2025년)

Cough Hypersensitivity Syndrome Global Market Report 2025

US $ 4,490 ￦ 6,183,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 8,938,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 11,692,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

기침 과민 증후군 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년까지 7.4%의 연평균 복합 성장률(CAGR)로 146억 5,000만 달러에 달할 것으로 예측됩니다. 예측 기간 동안의 성장은 전 세계 의료 접근성, 환자 옹호 및 지원, 삶의 질 향상에 기인합니다. 예측 기간의 주요 동향으로는 진단 및 스크리닝 도구의 개선, 개인화된 치료 접근법, 신약 등이 있습니다.

만성 호흡기 질환의 유병률 증가는 기침 과민 증후군 시장의 성장을 가속할 것으로 예상됩니다. 만성 호흡기 질환(CRD)은 폐와 호흡기에 영향을 미치는 다양한 장기 질환을 포함하며, 지속적인 호흡 장애와 폐 기능의 점진적인 저하를 초래합니다. 기침 과민 증후군의 치료는 증상 완화, 호흡 기능 개선, 천식 등 CRD 환자의 삶의 질 향상에 도움이 될 수 있습니다. 예를 들어, 2023년 6월 호주 보건 복지 연구소(Australian Institute of Health and Welfare)는 호주 인구의 약 30%인 750만 명이 만성 호흡기 질환을 앓고 있다고 보고했습니다. 또한, 2024년 5월 미국 국립보건통계센터(NCHS)는 성인 천식 유병률이 2021년 8.4%에서 2022년 8.7%로 증가했으며, 같은 기간 성인 천식 에피소드 발생률은 3.3%에서 3.7%로 상승했다고 밝혔습니다. 이처럼 만성 호흡기 질환 증가는 기침 과민 증후군 시장의 성장을 가속하고 있습니다.

담배를 피우는 사람 증가는 가까운 미래에 기침 과민 증후군 시장의 확장을 촉진하는 중요한 요인이 될 것으로 예상됩니다. 담배 흡연자는 담배 잎을 태워 발생하는 연기를 흡입하여 정기적으로 담배를 피우는 개인입니다. 담배는 기도를 자극하고 염증을 유발하며 폐 조직에 손상을 입혀 기침 과민 증후군을 유발합니다. 예를 들어, 2022년 7월 현재 캐나다 통계청은 2021년 6월에 비해 담배 생산량이 5.8% 증가했다고 보고했습니다. 또한 총 담배 판매량은 1.3% 증가하여 2022년 6월에는 14억 개비에 달했습니다. 또한 2023년 5월 미국 질병예방통제센터는 미국 성인 2830만 명이 담배를 피우고 있으며, 약 308만 명의 미국 중고등학생이 적어도 한 가지 이상의 담배 제품을 사용하고 있다고 밝혔습니다. 매일 약 1600명의 18세 미만 미국 청소년들이 첫 담배를 피우고 있습니다. 따라서 흡연자 인구 증가는 기침 과민 증후군 시장의 성장을 가속할 것으로 예상됩니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계 기침 과민 증후군 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인 및 억제요인)
• 최종 이용 산업 분석
• 세계의 기침 과민 증후군 시장 : 성장률 분석
• 세계의 기침 과민 증후군 시장 실적 : 규모와 성장, 2019-2024
• 세계의 기침 과민 증후군 시장 예측 : 규모와 성장, 2024-2029, 2034F
• 세계 기침 과민 증후군 전체 시장(TAM)

제6장 시장 세분화

• 세계의 기침 과민 증후군 시장 약제 클래스별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 흡입용 코르티코스테로이드
• 진해제
• 속효성 베타 2 작용제
• 항콜린제
• 양성자 펌프 억제제
• 항히스타민제
• 기타 약물
• 세계의 기침 과민 증후군 시장 : 투여 경로별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 경구
• 흡입
• 기타 투여 경로
• 세계의 기침 과민 증후군 시장 : 최종사용자별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 병원
• 전문 클리닉
• 홈케어
• 기타 최종사용자
• 세계의 기침 과민 증후군 시장 : 흡입 스테로이드제 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Budesonide
• Fluticasone
• Beclomethasone
• 세계의 기침 과민 증후군 시장 : 진해제 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Dextromethorphan
• Codeine
• Benzonatate
• 세계의 기침 과민 증후군 시장 : 속효성 베타 2 자극제 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Albuterol
• Levalbuterol
• 세계의 기침 과민 증후군 시장 : 항콜린제 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Ipratropium Bromide
• Tiotropium
• 세계의 기침 과민 증후군 시장 : 양성자 펌프 억제제 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Omeprazole
• Esomeprazole
• Lansoprazole
• 세계의 기침 과민 증후군 시장 : 항히스타민제 유형별 세분화, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• Cetirizine
• Loratadine
• Diphenhydramine
• 세계의 기침 과민 증후군 시장 : 기타 의약품별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 점액 용해제
• 병용요법제

제7장 지역별/국가별 분석

• 세계의 기침 과민 증후군 시장 : 지역별, 분석과 예측, 2019-2024, 2024-2029F, 2034F
• 세계의 기침 과민 증후군 시장 : 국가별, 분석과 예측, 2019-2024, 2024-2029F, 2034F

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 기침 과민 증후군 시장 : 경쟁 구도
• 기침 과민 증후군 시장 : 기업 개요
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson and Johnson Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

제31장 기타 주요 기업 및 혁신 기업

• Merck and Co Inc.
• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca Plc.
• GlaxoSmithKline Plc
• Takeda Pharmaceutical Company Limited
• Boehringer Ingelheim GmbH
• Wyeth Pharmaceuticals Inc.
• AstraZeneca Pharmaceuticals LP
• Teva Pharmaceutical Industries Ltd.
• Mylan N.V.
• Lupin Limited
• Cadila Pharmaceuticals
• Almirall S.A.
• Akorn Operating Company LLC

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 기침 과민 증후군 시장(2029년) : 새로운 기회를 제공하는 국가
• 기침 과민 증후군 시장(2029년) : 새로운 기회를 제공하는 부문
• 기침 과민 증후군 시장(2029년) : 성장 전략
  • 시장 동향에 근거한 전략
  • 경쟁 전략

제36장 부록

LSH

영문 목차

영문목차

Cough hypersensitivity syndrome (CHS) is a medical condition characterized by an exaggerated and abnormal response of the cough reflex to various stimuli, often leading to persistent and chronic coughing. It is commonly associated with conditions such as asthma, gastroesophageal reflux disease (GERD), and upper airway disorders.

The main drug types used for treating cough hypersensitivity syndrome include inhaled corticosteroids, antitussive agents, short-acting beta-2 agonists, anticholinergics, proton pump inhibitors, antihistamines, and others. Inhaled corticosteroids (ICS) refer to a class of medications used in the treatment of various respiratory conditions. These drugs can be administered orally, through inhalation, or by other means. They are utilized by various end-users, including hospitals, specialty clinics, homecare services, and others.

The cough hypersensitivity syndrome market research report is one of a series of new reports from The Business Research Company that provides cough hypersensitivity syndrome market statistics, including cough hypersensitivity syndrome industry global market size, regional shares, competitors with a cough hypersensitivity syndrome market share, detailed cough hypersensitivity syndrome market segments, market trends and opportunities and any further data you may need to thrive in the cough hypersensitivity syndrome industry. This cough hypersensitivity syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cough hypersensitivity syndrome market size has grown strongly in recent years. It will grow from $10.36 billion in 2024 to $11.03 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to increased awareness, telemedicine and remote monitoring, public health initiatives, research funding.

The cough hypersensitivity syndrome market size is expected to see strong growth in the next few years. It will grow to $14.65 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to global health access, patient advocacy and support, quality of life improvements. Major trends in the forecast period include improved diagnosis and screening tools, personalized treatment approaches, new medications.

The growing prevalence of chronic respiratory diseases is anticipated to drive the expansion of the cough hypersensitivity syndrome market. Chronic respiratory diseases (CRDs) encompass a range of long-term conditions affecting the lungs and airways, which lead to ongoing breathing challenges and gradual declines in lung function. Treatment for cough hypersensitivity syndrome helps alleviate symptoms, improve respiratory function, and enhance the quality of life for individuals with CRDs, such as asthma. For example, in June 2023, the Australian Institute of Health and Welfare reported that nearly 30% of the Australian population, or 7.5 million people, are affected by chronic respiratory diseases. Additionally, in May 2024, the National Center for Health Statistics (NCHS) in the United States indicated that adult asthma prevalence increased from 8.4% in 2021 to 8.7% in 2022, with asthma episode incidence for adults rising from 3.3% to 3.7% over the same period. Thus, the increasing occurrence of chronic respiratory diseases is fueling growth in the cough hypersensitivity syndrome market.

The increasing population of cigarette smokers is anticipated to be a significant factor propelling the expansion of the cough hypersensitivity syndrome market in the foreseeable future. Cigarette smokers are individuals who regularly engage in tobacco use by smoking cigarettes, involving the inhalation of smoke generated from burning tobacco leaves encased in a paper-wrapped cylinder. Cigarette smoking induces cough hypersensitivity syndrome by provoking irritation in the airways, inciting inflammation, and causing damage to lung tissues. For instance, as of July 2022, Statistics Canada reported a 5.8% increase in cigarette production compared to June 2021. Additionally, the total number of cigarettes sold rose by 1.3%, reaching 1.4 billion in June 2022. Furthermore, in May 2023, the Centers for Disease Control and Prevention revealed that an estimated 28.3 million U.S. adults are cigarette smokers, with about 3.08 million U.S. middle and high school students using at least one tobacco product. Each day, approximately 1,600 U.S. youth under the age of 18 try their first cigarette. Therefore, the growing population of cigarette smokers is expected to drive the growth of the cough hypersensitivity syndrome market.

Leading companies in the cough hypersensitivity syndrome market are prioritizing the development of advanced asthma treatments, such as rescue inhalers, to enhance patient outcomes and improve quality of life. Asthma rescue inhalers are compact devices designed to deliver quick-relief medication, helping to open airways rapidly. They provide relief from sudden coughing fits by temporarily easing airway sensitivity and reducing cough-related obstructions. For example, in April 2024, Teva Pharmaceutical Industries Ltd., an Israel-based pharmaceutical company, entered a partnership with Launch Therapeutics, a clinical development firm in the United States. This collaboration focuses on accelerating the clinical program for Teva's ICS-SABA inhaler, TEV-'248, which combines fluticasone propionate and albuterol sulfate, and is intended for both adult and pediatric asthma patients. This effort also aims to decrease dependency on generic treatments.

In June 2023, GlaxoSmithKline PLC, a prominent UK-based pharmaceutical and biotechnology company specializing in the production of drugs for cough hypersensitivity syndrome, completed the acquisition of Bellus Health Inc. for $2.0 billion. Through this strategic move, GSK aims to bolster its array of respiratory medications, as well as enhance its capabilities in research and development, production, and commercialization. Bellus Health Inc. is a biotechnology company based in Canada, known for its development of drugs tailored for cough hypersensitivity syndrome.

Major companies operating in the cough hypersensitivity syndrome market are Pfizer Inc., Johnson and Johnson Ltd., F. Hoffmann-La Roche AG, Bayer AG, Novartis AG, Merck and Co Inc., Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca Plc., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Boehringer Ingelheim GmbH, Wyeth Pharmaceuticals Inc., AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Mylan N.V., Lupin Limited, Cadila Pharmaceuticals, Almirall S.A., Akorn Operating Company LLC, Kudco Ireland Ltd., Prestige Consumer Healthcare Inc., GMP Laboratories of America Inc., The Betty Mills Company, Acura Pharmaceuticals Inc.

North America was the largest region in the cough hypersensitivity syndrome market in 2024. The regions covered in cough hypersensitivity syndrome report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the cough hypersensitivity syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The cough hypersensitivity syndrome market consists of sales of cough suppressants, steam inhalers and humidifiers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cough Hypersensitivity Syndrome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cough hypersensitivity syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cough hypersensitivity syndrome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cough hypersensitivity syndrome market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Inhales Corticosteroids; Antitussive Agents; Short-acting Beta-2 Agonists; Anticholinergics; Proton Pump Inhibitors; Antihistamines; Other Drugs
• 2) By Route of Administration: Oral; Inhalation; Other Route Of Administration
• 3) By End-User: Hospitals; Specialty Clinics; Homecare; Other End-Users
• Subsegments:
• 1) By Inhaled Corticosteroids: Budesonide; Fluticasone; Beclomethasone
• 2) By Antitussive Agents: Dextromethorphan; Codeine; Benzonatate
• 3) By Short-acting Beta-2 Agonists: Albuterol; Levalbuterol
• 4) By Anticholinergics: Ipratropium Bromide; Tiotropium
• 5) By Proton Pump Inhibitors: Omeprazole; Esomeprazole; Lansoprazole
• 6) By Antihistamines: Cetirizine; Loratadine; Diphenhydramine
• 7) By Other Drugs: Mucolytics; Combination Therapy Drugs
• Companies Mentioned: Pfizer Inc.; Johnson and Johnson Ltd.; F. Hoffmann-La Roche AG; Bayer AG; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cough Hypersensitivity Syndrome Market Characteristics

3. Cough Hypersensitivity Syndrome Market Trends And Strategies

4. Cough Hypersensitivity Syndrome Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Cough Hypersensitivity Syndrome Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cough Hypersensitivity Syndrome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cough Hypersensitivity Syndrome Market Growth Rate Analysis
• 5.4. Global Cough Hypersensitivity Syndrome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cough Hypersensitivity Syndrome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cough Hypersensitivity Syndrome Total Addressable Market (TAM)

6. Cough Hypersensitivity Syndrome Market Segmentation

• 6.1. Global Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Inhales Corticosteroids
• Antitussive Agents
• Short-acting Beta-2 Agonists
• Anticholinergics
• Proton Pump Inhibitors
• Antihistamines
• Other Drug
• 6.2. Global Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oral
• Inhalation
• Other Route Of Administration
• 6.3. Global Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Homecare
• Other End-Users
• 6.4. Global Cough Hypersensitivity Syndrome Market, Sub-Segmentation Of Inhaled Corticosteroids, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Budesonide
• Fluticasone
• Beclomethasone
• 6.5. Global Cough Hypersensitivity Syndrome Market, Sub-Segmentation Of Antitussive Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dextromethorphan
• Codeine
• Benzonatate
• 6.6. Global Cough Hypersensitivity Syndrome Market, Sub-Segmentation Of Short-Acting Beta-2 Agonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Albuterol
• Levalbuterol
• 6.7. Global Cough Hypersensitivity Syndrome Market, Sub-Segmentation Of Anticholinergics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ipratropium Bromide
• Tiotropium
• 6.8. Global Cough Hypersensitivity Syndrome Market, Sub-Segmentation Of Proton Pump Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Omeprazole
• Esomeprazole
• Lansoprazole
• 6.9. Global Cough Hypersensitivity Syndrome Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cetirizine
• Loratadine
• Diphenhydramine
• 6.10. Global Cough Hypersensitivity Syndrome Market, Sub-Segmentation Of Other Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mucolytics
• Combination Therapy Drugs

7. Cough Hypersensitivity Syndrome Market Regional And Country Analysis

• 7.1. Global Cough Hypersensitivity Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cough Hypersensitivity Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cough Hypersensitivity Syndrome Market

• 8.1. Asia-Pacific Cough Hypersensitivity Syndrome Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cough Hypersensitivity Syndrome Market

• 9.1. China Cough Hypersensitivity Syndrome Market Overview
• 9.2. China Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cough Hypersensitivity Syndrome Market

• 10.1. India Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cough Hypersensitivity Syndrome Market

• 11.1. Japan Cough Hypersensitivity Syndrome Market Overview
• 11.2. Japan Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cough Hypersensitivity Syndrome Market

• 12.1. Australia Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cough Hypersensitivity Syndrome Market

• 13.1. Indonesia Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cough Hypersensitivity Syndrome Market

• 14.1. South Korea Cough Hypersensitivity Syndrome Market Overview
• 14.2. South Korea Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cough Hypersensitivity Syndrome Market

• 15.1. Western Europe Cough Hypersensitivity Syndrome Market Overview
• 15.2. Western Europe Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cough Hypersensitivity Syndrome Market

• 16.1. UK Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cough Hypersensitivity Syndrome Market

• 17.1. Germany Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cough Hypersensitivity Syndrome Market

• 18.1. France Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cough Hypersensitivity Syndrome Market

• 19.1. Italy Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cough Hypersensitivity Syndrome Market

• 20.1. Spain Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cough Hypersensitivity Syndrome Market

• 21.1. Eastern Europe Cough Hypersensitivity Syndrome Market Overview
• 21.2. Eastern Europe Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cough Hypersensitivity Syndrome Market

• 22.1. Russia Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cough Hypersensitivity Syndrome Market

• 23.1. North America Cough Hypersensitivity Syndrome Market Overview
• 23.2. North America Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cough Hypersensitivity Syndrome Market

• 24.1. USA Cough Hypersensitivity Syndrome Market Overview
• 24.2. USA Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cough Hypersensitivity Syndrome Market

• 25.1. Canada Cough Hypersensitivity Syndrome Market Overview
• 25.2. Canada Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cough Hypersensitivity Syndrome Market

• 26.1. South America Cough Hypersensitivity Syndrome Market Overview
• 26.2. South America Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cough Hypersensitivity Syndrome Market

• 27.1. Brazil Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cough Hypersensitivity Syndrome Market

• 28.1. Middle East Cough Hypersensitivity Syndrome Market Overview
• 28.2. Middle East Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cough Hypersensitivity Syndrome Market

• 29.1. Africa Cough Hypersensitivity Syndrome Market Overview
• 29.2. Africa Cough Hypersensitivity Syndrome Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cough Hypersensitivity Syndrome Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cough Hypersensitivity Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cough Hypersensitivity Syndrome Market Competitive Landscape And Company Profiles

• 30.1. Cough Hypersensitivity Syndrome Market Competitive Landscape
• 30.2. Cough Hypersensitivity Syndrome Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson and Johnson Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Cough Hypersensitivity Syndrome Market Other Major And Innovative Companies

• 31.1. Merck and Co Inc.
• 31.2. Sanofi S.A.
• 31.3. Bristol-Myers Squibb Company
• 31.4. AstraZeneca Plc.
• 31.5. GlaxoSmithKline Plc
• 31.6. Takeda Pharmaceutical Company Limited
• 31.7. Boehringer Ingelheim GmbH
• 31.8. Wyeth Pharmaceuticals Inc.
• 31.9. AstraZeneca Pharmaceuticals LP
• 31.10. Teva Pharmaceutical Industries Ltd.
• 31.11. Mylan N.V.
• 31.12. Lupin Limited
• 31.13. Cadila Pharmaceuticals
• 31.14. Almirall S.A.
• 31.15. Akorn Operating Company LLC

32. Global Cough Hypersensitivity Syndrome Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cough Hypersensitivity Syndrome Market

34. Recent Developments In The Cough Hypersensitivity Syndrome Market

35. Cough Hypersensitivity Syndrome Market High Potential Countries, Segments and Strategies

• 35.1 Cough Hypersensitivity Syndrome Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cough Hypersensitivity Syndrome Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cough Hypersensitivity Syndrome Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료